Miparanom, Rodel B.
HRN: 22-69-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2023
AMPICILLIN 1GM (VIAL)
03/06/2023
03/12/2023
IV
560
Q4
Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes